Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain

Bora Inceoglu, Steven L. Jinks, Kara R. Schmelzer, Troy Waite, In Hae Kim, Bruce D. Hammock

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Soluble epoxide hydrolases catalyze the hydrolysis of epoxides in acyclic systems. In man this enzyme is the product of a single copy gene (EPXH-2) present on chromosome 8. The human sEH is of interest due to emerging roles of its endogenous substrates, epoxygenated fatty acids, in inflammation and hypertension. One of the consequences of inhibiting sEH in rodent inflammation models is a profound decrease in the production of pro-inflammatory and proalgesic lipid metabolites including prostaglandins. This prompted us to hypothesize that sEH inhibitors may have antinociceptive properties. Here we tested if sEH inhibitors can reduce inflammatory pain. Hyperalgesia was induced by intraplantar LPS injection and sEH inhibitors were delivered topically. We found that two structurally dissimilar but equally potent sEH inhibitors can be delivered through the transdermal route and that sEH inhibitors effectively attenuate thermal hyperalgesia and mechanical allodynia in rats treated with LPS. In addition we show that epoxydized arachidonic acid metabolites, EETs, are also effective in attenuating thermal hyperalgesia in this model. In parallel with the observed biological activity metabolic analysis of oxylipids showed that inhibition of sEH resulted with a decrease in PGD2 levels and sEH generated degradation products of linoleic and arachidonic acid metabolites with a concomitant increase in epoxides of linoleic acid. These data show that inhibition of sEH may become a viable therapeutic strategy to attain analgesia.

Original languageEnglish (US)
Pages (from-to)2311-2319
Number of pages9
JournalLife Sciences
Volume79
Issue number24
DOIs
StatePublished - Nov 10 2006

Fingerprint

Epoxide Hydrolases
Hyperalgesia
Metabolites
Rats
Epoxy Compounds
Linoleic Acid
Arachidonic Acid
Pain
Prostaglandin D2
Chromosomes
Bioactivity
Prostaglandins
Hydrolysis
Inflammation
Fatty Acids
Genes
Chromosomes, Human, Pair 8
Lipids
Degradation
Analgesia

Keywords

  • Arachidonic acid
  • EETs
  • Inflammation
  • Pain
  • Soluble epoxide hydrolase

ASJC Scopus subject areas

  • Pharmacology

Cite this

Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. / Inceoglu, Bora; Jinks, Steven L.; Schmelzer, Kara R.; Waite, Troy; Kim, In Hae; Hammock, Bruce D.

In: Life Sciences, Vol. 79, No. 24, 10.11.2006, p. 2311-2319.

Research output: Contribution to journalArticle

Inceoglu, Bora ; Jinks, Steven L. ; Schmelzer, Kara R. ; Waite, Troy ; Kim, In Hae ; Hammock, Bruce D. / Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. In: Life Sciences. 2006 ; Vol. 79, No. 24. pp. 2311-2319.
@article{50b4beecd7c54e43944e2a4dcd06807f,
title = "Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain",
abstract = "Soluble epoxide hydrolases catalyze the hydrolysis of epoxides in acyclic systems. In man this enzyme is the product of a single copy gene (EPXH-2) present on chromosome 8. The human sEH is of interest due to emerging roles of its endogenous substrates, epoxygenated fatty acids, in inflammation and hypertension. One of the consequences of inhibiting sEH in rodent inflammation models is a profound decrease in the production of pro-inflammatory and proalgesic lipid metabolites including prostaglandins. This prompted us to hypothesize that sEH inhibitors may have antinociceptive properties. Here we tested if sEH inhibitors can reduce inflammatory pain. Hyperalgesia was induced by intraplantar LPS injection and sEH inhibitors were delivered topically. We found that two structurally dissimilar but equally potent sEH inhibitors can be delivered through the transdermal route and that sEH inhibitors effectively attenuate thermal hyperalgesia and mechanical allodynia in rats treated with LPS. In addition we show that epoxydized arachidonic acid metabolites, EETs, are also effective in attenuating thermal hyperalgesia in this model. In parallel with the observed biological activity metabolic analysis of oxylipids showed that inhibition of sEH resulted with a decrease in PGD2 levels and sEH generated degradation products of linoleic and arachidonic acid metabolites with a concomitant increase in epoxides of linoleic acid. These data show that inhibition of sEH may become a viable therapeutic strategy to attain analgesia.",
keywords = "Arachidonic acid, EETs, Inflammation, Pain, Soluble epoxide hydrolase",
author = "Bora Inceoglu and Jinks, {Steven L.} and Schmelzer, {Kara R.} and Troy Waite and Kim, {In Hae} and Hammock, {Bruce D.}",
year = "2006",
month = "11",
day = "10",
doi = "10.1016/j.lfs.2006.07.031",
language = "English (US)",
volume = "79",
pages = "2311--2319",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "24",

}

TY - JOUR

T1 - Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain

AU - Inceoglu, Bora

AU - Jinks, Steven L.

AU - Schmelzer, Kara R.

AU - Waite, Troy

AU - Kim, In Hae

AU - Hammock, Bruce D.

PY - 2006/11/10

Y1 - 2006/11/10

N2 - Soluble epoxide hydrolases catalyze the hydrolysis of epoxides in acyclic systems. In man this enzyme is the product of a single copy gene (EPXH-2) present on chromosome 8. The human sEH is of interest due to emerging roles of its endogenous substrates, epoxygenated fatty acids, in inflammation and hypertension. One of the consequences of inhibiting sEH in rodent inflammation models is a profound decrease in the production of pro-inflammatory and proalgesic lipid metabolites including prostaglandins. This prompted us to hypothesize that sEH inhibitors may have antinociceptive properties. Here we tested if sEH inhibitors can reduce inflammatory pain. Hyperalgesia was induced by intraplantar LPS injection and sEH inhibitors were delivered topically. We found that two structurally dissimilar but equally potent sEH inhibitors can be delivered through the transdermal route and that sEH inhibitors effectively attenuate thermal hyperalgesia and mechanical allodynia in rats treated with LPS. In addition we show that epoxydized arachidonic acid metabolites, EETs, are also effective in attenuating thermal hyperalgesia in this model. In parallel with the observed biological activity metabolic analysis of oxylipids showed that inhibition of sEH resulted with a decrease in PGD2 levels and sEH generated degradation products of linoleic and arachidonic acid metabolites with a concomitant increase in epoxides of linoleic acid. These data show that inhibition of sEH may become a viable therapeutic strategy to attain analgesia.

AB - Soluble epoxide hydrolases catalyze the hydrolysis of epoxides in acyclic systems. In man this enzyme is the product of a single copy gene (EPXH-2) present on chromosome 8. The human sEH is of interest due to emerging roles of its endogenous substrates, epoxygenated fatty acids, in inflammation and hypertension. One of the consequences of inhibiting sEH in rodent inflammation models is a profound decrease in the production of pro-inflammatory and proalgesic lipid metabolites including prostaglandins. This prompted us to hypothesize that sEH inhibitors may have antinociceptive properties. Here we tested if sEH inhibitors can reduce inflammatory pain. Hyperalgesia was induced by intraplantar LPS injection and sEH inhibitors were delivered topically. We found that two structurally dissimilar but equally potent sEH inhibitors can be delivered through the transdermal route and that sEH inhibitors effectively attenuate thermal hyperalgesia and mechanical allodynia in rats treated with LPS. In addition we show that epoxydized arachidonic acid metabolites, EETs, are also effective in attenuating thermal hyperalgesia in this model. In parallel with the observed biological activity metabolic analysis of oxylipids showed that inhibition of sEH resulted with a decrease in PGD2 levels and sEH generated degradation products of linoleic and arachidonic acid metabolites with a concomitant increase in epoxides of linoleic acid. These data show that inhibition of sEH may become a viable therapeutic strategy to attain analgesia.

KW - Arachidonic acid

KW - EETs

KW - Inflammation

KW - Pain

KW - Soluble epoxide hydrolase

UR - http://www.scopus.com/inward/record.url?scp=33750529521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750529521&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2006.07.031

DO - 10.1016/j.lfs.2006.07.031

M3 - Article

VL - 79

SP - 2311

EP - 2319

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 24

ER -